Lynn Seely, President and CEO at Lyell Immunopharma, Inc. (LYEL), bought 175,000 shares at $0.61 ($107K) on 2025-03-14, disclosed to the SEC on 2025-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LYEL | SELL | 2026-06-15 | $7K | — | Filing → |
| LYEL | SELL | 2026-02-12 | $174K | — | Filing → |
| LYEL | SELL | 2026-02-11 | $10K | — | Filing → |